|
Why Evaluating Team Science is Important: Perspectives of the National Institutes of Health (NIH)
|
| Presenter(s):
|
| Sue Hamann, National Institutes of Health, sue.hamann@nih.gov
|
| Abstract:
The Roadmap for Medical Research was launched in 2004 by the National Institutes of Health to transform biomedical research. Many Roadmap programs, including the Interdisciplinary Research Consortium Program, funded research that was inherently risky. The Consortium Program differs from traditional programs in several ways: a) it spans multiple health and disease conditions; b) it is funded by multiple institutes within the National Institutes; and, c) it is costly, because, by its nature, team science consumes resources, both at the program (grantor) and project (grantee) levels. The Interdisciplinary Research Consortium Program was initially funded for five years and a decision about re-issuing the program will be made in late 2010. The national evaluation of the program will inform that decision by addressing the promise, risks, and costs of interdisciplinary research. In this paper, the key evaluation questions, methods, instruments, and national findings to date will be presented.
|
|